SPRI | Adult T-cell Leukemia/Lymphoma (2017 EN)

Discussion in 'Medicine' started by Kanka, Apr 28, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,047
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Toshiki Watanabe (Editor), Takuya Fukushima (Editor)
    Full Title: Adult T-cell Leukemia/Lymphoma
    Publisher: Springer; 1st ed. 2017 edition (May 11, 2017)
    Year: 2017
    ISBN-13: 9784431565239 (978-4-431-56523-9), 9784431565215 (978-4-431-56521-5)
    ISBN-10: 443156523X, 4431565213
    Pages: 169
    Language: English
    Genre: Internal Medicine
    File type: PDF (True)
    Quality: 10/10
    Price: 140.39 €


    This book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma (ATL). This rare but important disease has restricted endemic areas and distinct clinical features such as a high frequency of hypercalcemia, strong predisposition to infection and poor response to chemotherapy, aspects which set ATL apart from other types of non-Hodgkin lymphoma. Given the small number of patients, enrollment in clinical trials has not been feasible, and establishing treatment standard has been difficult but new evidence, such as results of nationwide studies on transplantation, have shown new insights and potential treatments. Based on recent evidence, the book presents new treatment methods for ATL and infection prevention of HTLV-1, enabling clinicians, researchers and post-docs specializing in hematology and virology to gain a valuable overview of the disease.

    -------------
     
    Last edited by a moderator: Dec 8, 2019